{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05579639",
            "orgStudyIdInfo": {
                "id": "2021-0537"
            },
            "secondaryIdInfos": [
                {
                    "id": "1UG3DE030401-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1UG3DE030401-01"
                }
            ],
            "organization": {
                "fullName": "Children's Hospital Medical Center, Cincinnati",
                "class": "OTHER"
            },
            "briefTitle": "Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant",
            "officialTitle": "Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant: a Randomized, Multicenter, Double-blind , Placebo-controlled Study Evaluating Twice Daily Oral Xylitol",
            "therapeuticArea": [
                "Other"
            ],
            "study": "xylitol-bsi-multisite-reduction-of-bloodstream-infections-from-oral-organisms-in-pediatric-stem-cell-transplant"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-11",
            "studyFirstSubmitQcDate": "2022-10-11",
            "studyFirstPostDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Children's Hospital Medical Center, Cincinnati",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Dental and Craniofacial Research (NIDCR)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Bloodstream infections (BSI) caused by bacteria translocating across injured oral mucosa are a significant cause of morbidity and mortality in patients undergoing stem cell transplantation (SCT). Unfortunately, there are currently no known strategies to prevent these BSI in this vulnerable population. The investigators will conduct a randomized, double-blind, placebo-controlled trial at three institutions to evaluate the effectiveness of twice daily intraoral xylitol-wipe application on reducing BSI in pediatric SCT patients.",
            "detailedDescription": "Patients will be randomized to receive either twice-daily intraoral grape-flavored xylitol-wipe (intervention arm) or grape-flavored saline wipe (control arm) application in addition to the current standard of care (SOC). The purpose of this study is to determine whether xylitol wipes are effective at reducing bloodstream infections (BSIs), dental plaque, mucositis (redness and ulcers in the mouth), or gingivitis in patients who undergo hematopoietic stem cell transplant."
        },
        "conditionsModule": {
            "conditions": [
                "Allogeneic Stem Cell Transplantation"
            ],
            "keywords": [
                "bloodstream infections",
                "oral health",
                "xylitol",
                "dental health",
                "gingivitis",
                "mucositis",
                "plaque"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "randomized, multicenter, double-blind, placebo-controlled",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "maskingDescription": "Participants, parents/guardians, nursing staff (interventionists), oral evaluators, and investigators will be blinded to the intervention, administered in the form of twice-daily grape-flavored xylitol wipes or grape-flavored saline wipes (controls). Preformed packets will be prepared by CCHMC Investigational Pharmacy staff, which will consist of either saline wipes with natural grape flavoring or xylitol. The color, taste, and smell of the wipes will be identical. The statistician will be unblinded to treatment assignment for the analysis.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 419,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Xylitol",
                    "type": "EXPERIMENTAL",
                    "description": "Xylitol, a naturally occurring sugar alcohol found in plums, strawberries, and various vegetables such as cauliflower, has been approved for use in food by the US FDA since 1963. Spiffies Xylitol Wipes will be used.",
                    "interventionNames": [
                        "Other: Xylitol"
                    ]
                },
                {
                    "label": "Grape-flavored Wipes",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Grape-flavored wipes will be used with 2 drops of PCCA colorless grape flavoring. The grape-flavored wipes each contain a solution of 0.9% Sodium Chloride, purified water, and Benzalkonium chloride. PCCA artificial colorless grape flavoring will be used. The PCCA grape flavoring contains propylene glycol, ethyl alcohol, and artificial flavoring.",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Xylitol",
                    "description": "Xylitol wipes",
                    "armGroupLabels": [
                        "Xylitol"
                    ],
                    "otherNames": [
                        "Spiffies Xylitol Wipes"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Placebo wipes",
                    "armGroupLabels": [
                        "Grape-flavored Wipes"
                    ],
                    "otherNames": [
                        "Grape-Flavored Wipes"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Bacteremia from an oral organism",
                    "description": "Incidence of bloodstream infection (BSI) from oral flora organisms in in patients receiving xylitol compared to placebo",
                    "timeFrame": "33 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Bacteremia from other non-oral flora organisms",
                    "description": "Incidence of BSI from non-oral flora organisms in patients receiving xylitol compared to placebo",
                    "timeFrame": "33 days"
                },
                {
                    "measure": "Dental plaque",
                    "description": "Debris Index Simplified (DI-S) score",
                    "timeFrame": "33 days"
                },
                {
                    "measure": "Gingivitis",
                    "description": "Mean Modified Gingival Index (MGI) score",
                    "timeFrame": "33 days"
                },
                {
                    "measure": "Objective mucositis",
                    "description": "Mean Oral Mucositis Assessment Scale (OMAS) score",
                    "timeFrame": "33 days"
                },
                {
                    "measure": "Patient-reported mucositis",
                    "description": "ChIMES total score",
                    "timeFrame": "33 days"
                },
                {
                    "measure": "Oral microbiome diversity",
                    "description": "Shannon Diversity Index",
                    "timeFrame": "33 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Provide signed and dated informed consent and assent (when applicable) form\n* Willing to comply with all study procedures and be available for the duration of the study\n* Admitted and planning to undergo an allogeneic stem cell transplant (SCT) at Cincinnati Children's Hospital Medical Center (CCHMC), Boston Children's Hospital, or Children's Hospital of Colorado (Denver).\n* Male or female, 4 months to 25 years of age at the time of SCT (Day 0)\n* Have a minimum of one tooth\n* Agree to avoid chewing gum and toothpaste that contains xylitol during the intervention period\n\nExclusion Criteria:\n\n* Prior radiation treatment for cancer of the oral cavity, head, or neck in the past 6 months per the study participant's medical record\n* Cranial boost in patients receiving total body irradiation\n* Known history of allergy to xylitol\n* Known history of allergy to grapes or grape flavoring\n* Undergoing a conditioning-free allogeneic stem cell transplant (patient does not receive any chemotherapy or radiation prior to stem cell infusion)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "4 Months",
            "maximumAge": "25 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kelly McIntosh",
                    "role": "CONTACT",
                    "phone": "513-803-0460",
                    "email": "Kelly.McIntosh@cchmc.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Christopher Dandoy, MD, MSc",
                    "affiliation": "Children's Hospital Medical Center, Cincinnati",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Children's Hospital Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanessa Fabrizio",
                            "role": "CONTACT",
                            "phone": "720-777-1982",
                            "email": "vanessa.fabrizio@cuanschutz.edu"
                        },
                        {
                            "name": "Vanessa Fabrizio, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Dana-Farber/Boston Children's",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Lehmann, MD",
                            "role": "CONTACT",
                            "phone": "617-632-3352",
                            "email": "leslie_lehmann@dfci.harvard.edu"
                        },
                        {
                            "name": "Paola Tabares",
                            "role": "CONTACT",
                            "email": "paola_tabares@dfci.harvard.edu"
                        },
                        {
                            "name": "Leslie Lehmann, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kelly McIntosh",
                            "role": "CONTACT",
                            "phone": "513-803-0460",
                            "email": "Kelly.McIntosh@cchmc.org"
                        },
                        {
                            "name": "Christopher Dandoy, MD, MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000018805",
                    "term": "Sepsis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018746",
                    "term": "Systemic Inflammatory Response Syndrome"
                },
                {
                    "id": "D000007249",
                    "term": "Inflammation"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "asFound": "Bloodstream Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26955",
                    "name": "Mucositis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9003",
                    "name": "Gingivitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M20818",
                    "name": "Systemic Inflammatory Response Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC07",
                    "name": "Mouth and Tooth Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "T173",
                    "name": "Grape",
                    "relevance": "LOW"
                },
                {
                    "id": "T303",
                    "name": "Strawberry",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}